EXPERIENCE OF USING THE NON­SELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

EXPERIENCE OF USING THE NON­SELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

Aim. To present the results of treatment with macitentan of patients included in the clinical trial SERAPHIN in Almazov National Medical Research Centre and define target therapy of pulmonary arterial hypertension (PAH) in real clinical practice.Material and methods. The article presents the results...

Full description

Bibliographic Details
Main Authors: M. A. Simakova, N. S. Goncharova, E. V. Karelkina, O. M. Moiseeva
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2018-04-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
легочная артериальная гипертензия
антагонисты рецепторов эндотелина
мацитентан
seraphin
Online Access:https://cardiovascular.elpub.ru/jour/article/view/802

Internet

https://cardiovascular.elpub.ru/jour/article/view/802

Similar Items